Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Jan-24 6:19 PM View:  | An2 Therapeutics, Inc. (ANTX) | 16-Jan-24 | Private Sale | 100,000 | $19.65 | $1,965,000.00 | (4%) 2.47M to 2.37M | |
| 16-Nov-23 6:57 PM View: | An2 Therapeutics, Inc. (ANTX) | 14-Nov-23 | Market Sale (Planned) | 1,810 | $16.15 | $29,224.30 | (< 1%) 2.48M to 2.47M | 7% |
| 03-Oct-23 10:00 PM View: | An2 Therapeutics, Inc. (ANTX) | 02-Oct-23 | Sale (Planned) | 5,672 | $16.07 | $91,149.00 | (< 1%) 2.48M to 2.48M | |
| 03-Oct-23 10:00 PM View: | An2 Therapeutics, Inc. (ANTX) | 29-Sep-23 | Private Sale (Planned) | 99,101 | $16.28 | $1,613,360.00 | (4%) 2.58M to 2.48M | |
| 29-Sep-23 5:40 PM View: | An2 Therapeutics, Inc. (ANTX) | 28-Sep-23 | Market Sale (Planned) | 8,516 | $16.11 | $137,193.00 | (< 1%) 5.18M to 5.17M | 7% |
| 29-Sep-23 5:40 PM View: | An2 Therapeutics, Inc. (ANTX) | 27-Sep-23 | Market Sale (Planned) | 841 | $16.07 | $13,514.90 | (< 1%) 5.18M to 5.18M | 7% |
| 15-Sep-23 5:40 PM View: | An2 Therapeutics, Inc. (ANTX) | 13-Sep-23 | Market Sale (Planned) | 400 | $16.00 | $6,400.00 | (< 1%) 2.59M to 2.59M | 6% |
| 08-Sep-23 4:57 PM View: | An2 Therapeutics, Inc. (ANTX) | 07-Sep-23 | Market Sale (Planned) | 3,378 | $16.05 | $54,216.90 | (< 1%) 2.59M to 2.59M | 6% |
| 08-Sep-23 4:57 PM View: | An2 Therapeutics, Inc. (ANTX) | 06-Sep-23 | Market Sale (Planned) | 3,762 | $16.02 | $60,267.20 | (< 1%) 2.6M to 2.59M | 6% |
| 25-Aug-23 4:30 PM View: | An2 Therapeutics, Inc. (ANTX) | 23-Aug-23 | Market Sale | 400 | $16.00 | $6,400.00 | (< 1%) 2.6M to 2.6M | 6% |
| 24-Jun-22 5:10 PM View: | An2 Therapeutics, Inc. (ANTX) | 06-Jun-22 | Acquisition (other) Duplicate | 26,511 | $15.00 | $397,665.00 | 1% 2.6M to 2.62M | < 1% |
| 24-Jun-22 5:10 PM View: | An2 Therapeutics, Inc. (ANTX) | 06-Jun-22 | Disposition (other) Duplicate | 26,511 | $15.00 | $397,665.00 | (1%) 2.62M to 2.6M | (< 1%) |
| 31-Mar-22 8:15 PM View: | An2 Therapeutics, Inc. (ANTX) | 29-Mar-22 | Conversion | 2,430,710 | -- | -- | 100% 0 to 2.43M | |
| 31-Mar-22 8:15 PM View: | An2 Therapeutics, Inc. (ANTX) | 29-Mar-22 | Market Purchase | 166,666 | $15.00 | $2,499,990.00 | 7% 2.43M to 2.6M |